Perez, M., Muñoz-Galván, S., Jiménez-García, M. P., Marín, J. J., & Carnero, A. (2015). Efficacy of CDK4 inhibition against sarcomas depends on their levels of CDK4 and p16ink4 mRNA. Oncotarget.
Chicago-stil citatPerez, Marco, Sandra Muñoz-Galván, Manuel P. Jiménez-García, Juan J. Marín, och Amancio Carnero. "Efficacy of CDK4 Inhibition against Sarcomas Depends On Their Levels of CDK4 and P16ink4 MRNA." Oncotarget 2015.
MLA-referensPerez, Marco, et al. "Efficacy of CDK4 Inhibition against Sarcomas Depends On Their Levels of CDK4 and P16ink4 MRNA." Oncotarget 2015.
Varning: dessa hänvisningar är inte alltid fullständigt riktiga.